Type 2

CureusLuseogliflozin Suppresses Late-Night Basal Glycemic Variability in Type 2 Diabetes: A Retrospective Observational StudyIntroduction: Glucose fluctuations have been implicated in the development of diabetic macroangiopathy. Sodium-glucose cotransporter 2….6 hours ago

News Source0202 views

CureusLuseogliflozin Suppresses Late-Night Basal Glycemic Variability in Type 2 Diabetes: A Retrospective Observational StudyIntroduction: Glucose fluctuations have been implicated in the development of diabetic macroangiopathy. Sodium-glucose cotransporter 2….6 hours ago

Related posts

WVU Medicine endocrinologist highlights steps to prevent and manage diabetes

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Dexcom unveils Type 2 diabetes CGM data at ATTD